or Try an Advanced Search...

    Technical Analysis for LFCR - Lifecore Biomedical, Inc.

    Grade Last Price % Change Price Change
    C 7.31 4.73% 0.33
    LFCR closed up 4.73 percent on Friday, November 22, 2024, on 1.23 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical LFCR trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Slingshot Bullish Bullish Swing Setup 4.73%
    Wide Range Bar Range Expansion 4.73%
    Upper Bollinger Band Walk Strength 4.73%
    Outside Day Range Expansion 4.73%
    Wide Bands Range Expansion 4.73%
    Overbought Stochastic Strength 4.73%
    Older End-of-Day Signals for LFCR ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 1 day ago
    Gap Up Partially Closed 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    Up 5% 1 day ago
    Up 1 ATR 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    LFCR Chart by TradingView
    Basic chart:

    Profile

    Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.
    Classification
    Sector: Consumer Defensive
    Industry: Farm Products
    Keywords: Biotechnology Life Sciences Acid Natural Sciences Contract Manufacturing Organization Hyaluronic Acid Glycosaminoglycans

    Is LFCR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Lifecore Biomedical to Present at Stephens Annual Investment Conference
    Nov 12 Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) top owners are retail investors with 35% stake, while 35% is held by hedge funds
    Nov 12 Lifecore Biomedical: Finally A 'Pure Play' CDMO Business
    Nov 4 Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
    Oct 11 Lifecore Biomedical GAAP EPS of -$0.53, revenue of $24.7M
    Oct 7 Lifecore Biomedical Inc (LFCR) Q1 2025 Earnings Call Transcript Highlights: Navigating ...
    Oct 4 Lifecore Biomedical, Inc. (LFCR) Q1 2025 Earnings Call Transcript
    Oct 4 Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
    Oct 4 Lifecore Biomedical raises $24.3M through private placement
    Oct 4 Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
    See more LFCR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.9
    52 Week Low 3.6793
    Average Volume 168,640
    200-Day Moving Average 5.91
    50-Day Moving Average 5.58
    20-Day Moving Average 6.48
    10-Day Moving Average 6.90
    Average True Range 0.43
    RSI (14) 64.79
    ADX 39.26
    +DI 38.40
    -DI 10.95
    Chandelier Exit (Long, 3 ATRs) 6.69
    Chandelier Exit (Short, 3 ATRs) 6.64
    Upper Bollinger Bands 7.58
    Lower Bollinger Band 5.37
    Percent B (%b) 0.88
    BandWidth 34.07
    MACD Line 0.48
    MACD Signal Line 0.43
    MACD Histogram 0.0418
    Fundamentals Value
    Market Cap 215.74 Million
    Num Shares 29.5 Million
    EPS -2.30
    Price-to-Earnings (P/E) Ratio -3.18
    Price-to-Sales 2.44
    Price-to-Book 1.57
    PEG Ratio 3.51
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.91
    Resistance 3 (R3) 7.89 7.67 7.81
    Resistance 2 (R2) 7.67 7.52 7.68 7.78
    Resistance 1 (R1) 7.49 7.43 7.58 7.51 7.74
    Pivot Point 7.27 7.27 7.32 7.28 7.27
    Support 1 (S1) 7.09 7.12 7.18 7.11 6.88
    Support 2 (S2) 6.87 7.03 6.88 6.84
    Support 3 (S3) 6.69 6.87 6.81
    Support 4 (S4) 6.71